A randomized Phase II/III trial of 3 weekly intraperitoneal versus intravenous carboplatin in combination with intravenous weekly dose-dense paclitaxel for newly diagnosed ovarian, fallopian tube and primary peritoneal cancer.
Fujiwara
Keiichi
K
Department of Gynecologic Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-City, Saitama 350-1298, Japan. fujiwara@saitama-med.ac.jp
Aotani
Eriko
E
Hamano
Tetsutaro
T
Nagao
Shoji
S
Yoshikawa
Hiroyuki
H
Sugiyama
Toru
T
Kigawa
Junzo
J
Aoki
Daisuke
D
Katsumata
Noriyuki
N
Takeuchi
Masahiro
M
Suzuki
Mitsuaki
M